Developed by Butantan, the vaccine against Covid-19 received approval from Anvisa for the first tests in humans on Wednesday, 9th; compound must also be adjusted to combat new coronavirus strains.
A butanvac, vaccine against Covid-19 developed by Butantan Institute, can also be used to immunize against the flu. The forecast was made by the Secretary of Health of the State of Sao Paulo, Jean Gorinchteyn, was released on Thursday, 10, a day after the National Health Surveillance Agency (Anvisa) release the first tests of the immunizing agent in humans. According to Butantan, research into the use of the new vaccine against the coronavirus and against the influenza virus, which causes the flu, are already underway. However, the results are not expected until next year. According to Gorinchteyn, another advantage of the compound is that, because it uses the same technology as the flu vaccine, with regular updates to protect against mutations, the vaccine would be able to be adjusted to combat variants of the flu. coronavirus.
The Health secretary also stated that São Paulo should have a new “D-Day” of vaccination against the Covid-19. About 340,000 people have not yet returned to receive the second dose in the state. “Call out to the population so that those who didn’t go, are going. Let them take their fathers, mothers, grandparents, because vaccinating is a gesture of love, of protecting life”, he said. Until this Thursday, São Paulo had applied 18 million 897 thousand 892 vaccines against the coronavirus, with 5,939,413 of which were the second dose.
*With information from the reporter Nanny Cox